Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Urologia Internationalis|May 8, 2014
Management of bone metastases in patients with castration-resistant prostate cancerRichard Cathomas, Zoltan Bajory, Mounira Bouzid, et al.Asia-Pacific Journal of Clinical Oncology|March 1, 2014
EGFR gene mutations in patients with adenosquamous lung carcinomaTomasz Powrózek, Paweł Krawczyk, Rodryg Ramlau, et al.Journal of Personalized Medicine|April 28, 2023
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate CancerWojciech A Cieślikowski, Piotr Milecki, Monika Świerczewska, et al.Lancet (London, England)|March 1, 2011
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyKarim Fizazi, Michael Carducci, Matthew Smith, et al.European Urology|December 3, 2014
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate CancerKarim Fizazi, Christophe Massard, Matthew Smith, et al.Cancers|January 16, 2020
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate CancerWojciech A Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 24, 2017
Improving radiation oncology through clinical audits: Introducing the IROCA projectMaria Glòria Torras, Magdalena Fundowicz, Luisa Aliste, et al.Scientific Reports|June 11, 2021
Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centresCarla Lopes de Castro, Magdalena Fundowicz, Alvar Roselló, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate CancerCora Sternberg, Andrew Armstrong, Roberto Pili, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2020
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459)Gerd Fastner, Roland Reitsamer, Bartosz Urbański, et al.Pageof 7